Development and maintenance of chronic toxoplasmosis
慢性弓形虫病的发展和维持
基本信息
- 批准号:10374148
- 负责人:
- 金额:$ 67.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-03-17 至 2026-02-28
- 项目状态:未结题
- 来源:
- 关键词:5&apos Untranslated RegionsAddressBindingBrainCRISPR screenCategoriesCell Culture TechniquesChromatinChronicComplementCystDataDevelopmentDiseaseDisease ReservoirsDown-RegulationElementsEnvironmental Risk FactorEventExposure toFailureFoundationsFutureGenesGeneticGenetic TranscriptionGoalsHomeostasisImmunocompetentImmunocompromised HostIndividualInfectionLesionLicensingLifeLinkMaintenanceMediatingMessenger RNAMolecularMonitorMusMutation AnalysisNational Institute of Allergy and Infectious DiseaseNucleic Acid BindingParasitesPathway interactionsPopulationPrevalenceProcessProteinsProteomicsRNARecurrenceRegulationRegulatory PathwayReporterResistanceResolutionRibosomesRoleStressStructureTissuesToxoplasmaToxoplasma gondiiToxoplasmosisTranscriptTranscriptional RegulationTranslational RegulationTranslationsVideo MicroscopyVirulenceWorkacute infectionalkalinitybasebiodefensecurative treatmentsinsightmouse modelpreventprogramspromoterresponseribosome profilingscreeningtranscription factortranscriptome sequencing
项目摘要
7. PROJECT SUMMARY/ABSTRACT
Chronic Toxoplasma gondii infections are widespread and their reactivation can cause life-threatening disease in
immunocompromised individuals and recurrent ocular lesions in the immunocompetent. The recently identified
master regulator of chronic differentiation, BFD1, provides an unprecedented opportunity to investigate the
molecular events that establish and maintain chronic T. gondii infections. BFD1 is necessary for chronic
differentiation in cell culture and in mouse models of infection, and its expression is sufficient to induce chronic
differentiation. Consistent with a sustained requirement for BFD1 during chronic stage maintenance, the
differentiation program is reversed upon conditional down-regulation of BFD1. Preliminary results indicate that BFD1
is post-transcriptionally controlled through its 5′ UTR, leading to the hypothesis that translational regulation of BFD1
is fundamental to the development and maintenance of chronic T. gondii stages. This proposal seeks to integrate
BFD1 into a broader regulatory network through three complementary aims. Aim 1 will examine the sequence
elements, secondary RNA structures, and ribosomal occupancy dynamics that mediate BFD1 translational
regulation. Aim 2 will use conditional depletion of BFD1 to characterize transcriptional and proteomic changes that
mediate reactivation, and the molecular circuits that maintain the differentiated state. Finally, Aim 3 will extend the
regulatory pathways that control differentiation by screening for genes involved in the translational regulation of BFD1
and further examining the function of transcription factors directly regulated by BFD1. The overarching goal of this
comprehensive analysis is to understand the conditions that promote chronic differentiation and license the
development of curative therapies against toxoplasmosis.
7。项目摘要/摘要
慢性弓形虫感染是广泛的,它们的重新激活会导致威胁生命的疾病
免疫功能低下的个体和免疫能力的复发性眼病变。最近确定的
长期差异化的主要监管者BFD1为调查调查提供了前所未有的机会
建立和维持慢性T. gondii感染的分子事件。 BFD1对于慢性是必需的
细胞培养和小鼠感染模型的分化,其表达足以诱导慢性
分化。与在慢性阶段维护期间对BFD1的持续要求一致
在BFD1的有条件下调时,差异化程序会逆转。初步结果表明BFD1
在转录后通过其5'UTR进行控制,导致假设翻译了BFD1的调节
对于慢性T. gondii阶段的发展和维护至关重要。该建议旨在整合
BFD1通过三个完整目标进入更广泛的监管网络。 AIM 1将检查序列
元素,次级RNA结构和核糖体占用动力学,介导BFD1翻译
规定。 AIM 2将使用BFD1的条件部署来表征转录和蛋白质组学变化
培养基重新激活,以及维持分化状态的分子电路。最后,AIM 3将扩展
通过筛选涉及BFD1翻译调节的基因来控制分化的调节途径
并进一步研究了直接由BFD1调节的转录因子的功能。总体目标
全面的分析是了解促进长期差异和许可的条件
针对弓形虫病的治疗疗法的开发。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sebastian Lourido其他文献
Sebastian Lourido的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sebastian Lourido', 18)}}的其他基金
Development and maintenance of chronic toxoplasmosis
慢性弓形虫病的发展和维持
- 批准号:
10181740 - 财政年份:2021
- 资助金额:
$ 67.13万 - 项目类别:
Development and maintenance of chronic toxoplasmosis
慢性弓形虫病的发展和维持
- 批准号:
10579245 - 财政年份:2021
- 资助金额:
$ 67.13万 - 项目类别:
Control of parasite invasion by a microneme protein complex conserved in Apicomplexans
顶复门中保守的微线体蛋白复合物控制寄生虫入侵
- 批准号:
10531601 - 财政年份:2019
- 资助金额:
$ 67.13万 - 项目类别:
Control of parasite invasion by a microneme protein complex conserved in Apicomplexans
顶复门中保守的微线体蛋白复合物控制寄生虫入侵
- 批准号:
9886387 - 财政年份:2019
- 资助金额:
$ 67.13万 - 项目类别:
Control of parasite invasion by a microneme protein complex conserved in Apicomplexans
顶复门中保守的微线体蛋白复合物控制寄生虫入侵
- 批准号:
10302285 - 财政年份:2019
- 资助金额:
$ 67.13万 - 项目类别:
Control of parasite invasion by a microneme protein complex conserved in Apicomplexans
顶复门中保守的微线体蛋白复合物控制寄生虫入侵
- 批准号:
10062827 - 财政年份:2019
- 资助金额:
$ 67.13万 - 项目类别:
Identification of novel Toxoplasma genes involved in host-parasite interactions
鉴定参与宿主-寄生虫相互作用的新弓形虫基因
- 批准号:
9203042 - 财政年份:2016
- 资助金额:
$ 67.13万 - 项目类别:
Dissecting essential signaling pathways in apicomplexan parasites
剖析顶端复门寄生虫的重要信号通路
- 批准号:
8609230 - 财政年份:2013
- 资助金额:
$ 67.13万 - 项目类别:
Dissecting essential signaling pathways in apicomplexan parasites
剖析顶端复门寄生虫的重要信号通路
- 批准号:
8737992 - 财政年份:2013
- 资助金额:
$ 67.13万 - 项目类别:
Dissecting essential signaling pathways in apicomplexan parasites
剖析顶端复门寄生虫的重要信号通路
- 批准号:
9349383 - 财政年份:2013
- 资助金额:
$ 67.13万 - 项目类别:
相似海外基金
Emerging mechanisms of viral gene regulation from battles between host and SARS-CoV-2
宿主与 SARS-CoV-2 之间的战斗中病毒基因调控的新机制
- 批准号:
10725416 - 财政年份:2023
- 资助金额:
$ 67.13万 - 项目类别:
Targeting HNF4-induced thrombo-inflammation in Chagas disease
针对恰加斯病中 HNF4 诱导的血栓炎症
- 批准号:
10727268 - 财政年份:2023
- 资助金额:
$ 67.13万 - 项目类别:
Optimization of CRISPR genome editor and its delivery strategy for C9orf72 frontotemporal dementia
C9orf72额颞叶痴呆的CRISPR基因组编辑器优化及其递送策略
- 批准号:
10746565 - 财政年份:2023
- 资助金额:
$ 67.13万 - 项目类别: